// App-Quantinova.ai

2695 : Targeted therapy of leukemia and Ewing's sarcoma by human antibody-targeted nanoparticles

Researchers

Presenter

  • Hyunggyoo Kang

Principal Investigators

  • Jon Nagy

  • Timothy Trivhe

Medical Centers

  • Children's Hosp Los Angeles, Los Angeles, CA

  • Nano Valent Phamaceuticals, Bozeman, MT.

Locations

  • United States

Companies

  • NanoValent Pharmaceu

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Ewing's sarcoma

  • Solid malignancies

Biomarkers

  • Breakpoint Cluster Region

Drug/Treatment

  • Doxorubicin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved